Clinical presentation and outcome of patients with post-transplant NTM disease
| Patient | Diagnosis | NTM | Sensitivities | Treatment | Duration | Outcome |
|---|---|---|---|---|---|---|
| NTM, non-tuberculous mycobacteria; BOS, bronchiolitis obliterans syndrome; MAC, Mycobacterium avium complex. | ||||||
| 1 | Sternal wound abscess/mediastinitis | M abscessus | Amikacin, azithromycin, clarithromycin, ciprofloxcin, cefoxitin | Cefoxitin,azithromycin,amikacin | 48 months | Died 10 years after transplant from multiple problems |
| 2 | Sternal wound abscess/empyema | M abscessus | Amikacin, azithromycin, clarithromycin, ciprofloxcin, cefoxitin | Clarithromycin, amikacin, cefoxitin | 27 months | Normal graft function at follow up |
| 3 | New pulmonary infiltrates | MAC | Not obtained | Refused treatment as had severe BOS | Died | |
| 4 | New pulmonary infiltrates | M kansasii | Amikacin, clarithromycin, ciprofloxcin, rifabutin, isoniazid, rifampin, streptomycin, ethambutol | Isoniazid, ciprofloxin, rifabutin, ethambutol | 2 months | Normal graft function at follow up |
| 39 | Lung abscess and mediastinal lymphadenapathy | M abscessus | Amikacin, azithromycin, clarithromycin, ofloxacin, ciprofloxcin, cefoxitin | Clarithromycin, ofloxacin cefoxitin | 11 months | Died of disseminated mucomycosis |